The Influence of Radiotherapy on Cognitive Function

Sponsor
Tel-Aviv Sourasky Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00457210
Collaborator
Mindstreams (Other)
150
1

Study Details

Study Description

Brief Summary

The cognitive function of 150 patients that undergone any Radiotherapy treatment to the brain will be assessed at 3 time points before and after the treatment.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Brain Radiotherapy/Stereotactic Radiosurgery

Detailed Description

The basic cognitive function and QOL of 150 oncologic patients that undergone Radiotherapy or Radiosurgery treatment to the brain due to primary tumor, metastases or increased risk of brain metastases, will be assessed at 3 time points: before the treatment, immediately after the treatment, and on the next follow up visit. The assessment tools that will be used are Neurotrax standard cognitive computerized tests and 2 short questionnaires.Patients that will receive a one-day treatment will be tested on 2 time points only- before the treatment and on FU.The research will reveal the positive and the negative influences of the Radiotherapy, along with the assessment of norms for the cognitive function and quality of life of oncologic patients being treated by RT.Eligibility criteria:oncologic patients of both genders, with primary brain tumors, metastases or with increased risk of brain metastases, that are referred to conformal/palliative or preventive Radiotherapy treatment or to Stereotactic Radiosurgery, who are able to follow instructions in Hebrew.The participants will be 20-80 years old.Main comparisons will be performed between the cognitive tests results on 3 time points mentioned. The study will continue until the needed number of participants will be achieved.

Study Design

Study Type:
Observational
Observational Model:
Defined Population
Time Perspective:
Other
Official Title:
The Influence of the Radiotherapy or Stereotactic Radiosurgery on the Cognitive Function of the Patients With the Neurotrax Assessment System and a Cognitive Questionnaire.
Study Start Date :
Apr 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 20-80 years old oncologic patients, of both genders, that are referred to Brain Radiotherapy or Stereotactic Radiosurgery due to primary brain tumor/ brain metastases or increased risk for brain metastases.

    • Are able to follow instructions in Hebrew.

    Exclusion Criteria:
    • Non-Hebrew speakers can not participate.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Tel Aviv sourasky Medical Center Tel Aviv Israel 64239

    Sponsors and Collaborators

    • Tel-Aviv Sourasky Medical Center
    • Mindstreams

    Investigators

    • Principal Investigator: Ben Corn, PhD, Tel-Aviv Sourasky Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00457210
    Other Study ID Numbers:
    • TASMC-07-BC-040-CTIL
    First Posted:
    Apr 6, 2007
    Last Update Posted:
    Apr 6, 2007
    Last Verified:
    Apr 1, 2007
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 6, 2007